Comparative risk of cerebral venous sinus thrombosis (CVST) following COVID-19 vaccination or infection: A national cohort study using linked electronic health records
To inform the public and policy makers, we investigated and compared the risk of cerebral venous sinus thrombosis (CVST) after SARS-Cov-2 vaccination or infection using a national cohort of 2,643,699 individuals aged 17 y and above, alive, and resident in Wales on 1 January 2020 followed up through...
Main Authors: | Columbus Ohaeri, Daniel Rhys Thomas, Jane Salmon, Simon Cottrell, Jane Lyons, Ashley Akbari, Ronan A Lyons, Fatemeh Torabi, Gareth GI Davies, Christopher Williams |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-11-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2022.2127572 |
Similar Items
-
Letter in Reply: Thrombophilic Evaluation in Cases of Cerebral Venous Sinus Thrombosis
by: Sudhir Kumar Palat Chirakkara
Published: (2018-11-01) -
Cerebral venous sinus thrombosis (CVST) associated with SARS-CoV-2 vaccines: clues for an immunopathogenesis common to CVST observed in COVID-19
by: Anna Teresa Mazzeo, et al.
Published: (2021-11-01) -
Deep venous sinus thrombosis with right thalamic infarction in a young patient after COVID-19 vaccination
by: Suraj Sharma, MBBS, et al.
Published: (2022-09-01) -
Cerebral venous sinus thrombosis
by: M. V. Glebov, et al.
Published: (2017-02-01) -
Clinical analysis of traumatic cerebral venous sinus thrombosis in children
by: ZHAO Xueling, et al.
Published: (2020-11-01)